Covid-19

COVID-19: Proactive Action Plan

Verona, Italy (24 November 2020) – In anticipation of the second wave of COVID-19 pandemic and in order to safeguard our employees’ wellbeing as well as our clients’ interests, starting from February CROS NT  has taken and continues to apply and review the following actions as a precautionary measure in our offices around the world:…

Webinar Leveraging Digital Transformation: How to Approach Decentralised Trials

Webinar: Leveraging Digital Transformation: How to Approach Decentralised Trials

On the 3rd of December, we will conduct a new webinar titled “Leveraging Digital Transformation: How to Approach Decentralised Trials” and it would be our pleasure to have you among participants. Click here to register now for the webinar The COVID-19 pandemic has significantly impacted the Life Science industry’s attitude towards technology and accelerated innovative approaches.…

Chief Commercial Officer Angela Weston

PM Holding Appoints Angela Weston as Chief Commercial Officer

Verona, Italy (11 September 2019) – PM Holding, a group of diverse service providers in the life sciences industry, announces the appointment of Angela Weston as Chief Commercial Officer to manage business development operations across the entire group. PM Holding consists of specialized service providers in the drug and device development sector including: CROS NT…

chief operating officer Sébastian Gerin

CROS NT Appoints Sébastien Gerin as Chief Operating Officer

Verona, Italy (20 August 2019) – CROS NT announces that Sébastien Gerin has recently joined its global team in the role of Chief Operating Officer. Sébastien stepped into the new position this June as CROS NT continues to expand its global operations in terms of expert biometrics services and full service capacity in select geographic…

Partnership

CROS NT Announces Extended Partnership with Medidata – Deploys RaveX

23 May 2017 (Maidenhead, UK and Chapel Hill, NC, USA) – CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata. Under the partnership, CROS NT will offer its customers with RaveX—the latest generation of Medidata’s industry-leading EDC system, Medidata Rave®—as well as Medidata’s randomization and trial supply management…

Asthma Study

CROS NT Biostatisticians Co-Author Moderate Asthma Study Results in The Lancet Medical Journal

CROS NT’s Chairman, Paolo Morelli, and biostatistician, Marco Pannacci, are co-authors on a recent paper published in The Lancet Respiratory Medicine featuring the results of a moderate asthma clinical trial sponsored by the Italian Medicines Agency (AIFA). The full article can be found on the Lancet’s website. Paolo Morelli, given his statistical experience and background…

CROS NT Ltd Announces Acquisition of MDSL International Ltd.

As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International – a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential. CROS NT Ltd, the UK branch of CROS…

CROS NT SRL Announces Acquisition of Stat-Tech Services, LLC

To fulfill the need for global biometrics solutions, CROS NT SRL today announced the acquisition of Stat-Tech Services, LLC – a Contract Research Organization (CRO) with extensive expertise in the medical devices sector. The financial details of the transaction remain confidential. CROS NT, an international CRO specializing in biometrics services, see the acquisition as an…

DATATRAK

CROS NT Joins DATATRAK Connect™ Partner Program

CROS NT has expanded its life sciences technology portfolio by joining the DATATRAK Connect™ Program – a program which allows for extended service offerings for the drug development process with the goal of reducing study costs and furthering business development objectives. Under this partnership program, CROS NT can provide DATATRAK’s clinical trial technologies including Electronic…